PhotoMed Technologies, Inc. – Trademark Portfolio
Entity Type: 03
PhotoMed Technologies, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 9 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include VARICHROME and PHOTOMED TECHNOLOGIES. The owner is based in Kensington, CA.
65 Franciscan Way
Kensington, CA 94707
Showing of trademarks Trademarks
Trademark Classifications
PhotoMed Technologies, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does PhotoMed Technologies, Inc. have?
PhotoMed Technologies, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned, 4 cancelled.
What trademark classes does PhotoMed Technologies, Inc. file in?
PhotoMed Technologies, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are PhotoMed Technologies, Inc.'s most well-known trademarks?
PhotoMed Technologies, Inc.'s registered trademark portfolio includes well-known marks such as VARICHROME and PHOTOMED TECHNOLOGIES. These are among 2 currently registered trademarks in the portfolio.
What is PhotoMed Technologies, Inc.'s trademark registration success rate?
PhotoMed Technologies, Inc. has a 20% trademark registration rate, with 2 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.